Showing results (61-70 of 411) with videos related to
Sort By:
Pageof 42
Turkish Journal of Biology = Turk Biyoloji Dergisi|April 2, 2019
Protein engineering approaches for antibody fragments: directed evolution and rational design approachesMerve Arslan, Dilara Karadağ, Sibel KalyoncuTurkish Journal of Biology = Turk Biyoloji Dergisi|April 2, 2019
Response of breast cancer cells to IFNα-2b in 2D and 3D cell culturesTetiana Herheliuk, Olena Perepelytsina, Andrij Ugnivenko, et al.Turkish Journal of Biology = Turk Biyoloji Dergisi|April 2, 2019
Comparison of indigo carmine decolorization by Pseudomonas aeruginosa and crude laccase enzyme from Funalia trogiiFiliz Boran, Emre Birhanli, Özfer Yeşilada, et al.Turkish Journal of Biology = Turk Biyoloji Dergisi|April 2, 2019
Development of antimicrobial gelatin films with boron derivativesSanem Argin, Merve Gülerim, Fikrettin ŞahinTurkish Journal of Biology = Turk Biyoloji Dergisi|April 2, 2019
Prediction and expression analysis of G protein-coupled receptors in the laboratory stick insect, Carausius morosusBurçin Duan Şahbaz, Necla Birgül IyisonTurkish Journal of Biology = Turk Biyoloji Dergisi|January 7, 2026
Corrigendum to "miR-9-5p alleviates the development of abdominal aortic aneurysm by regulating the differentiation of CD4+IL-10+T cells via targeting the crosstalk between Nrf2 and NF-κB signaling pathways" [Turkish Journal of Biology 49 (4) 2025 380-391]Hongfu Liu, Jinyi Zhang, Lubin Li, et al.Turkish Journal of Biology = Turk Biyoloji Dergisi|June 30, 2020
SARS-CoV-2 isolation and propagation from Turkish COVID-19 patientsCihan TaŞtan, Bulut Yurtsever, Gözde Sir KarakuŞ, et al.Turkish Journal of Biology = Turk Biyoloji Dergisi|June 30, 2020
Gut-lung axis and dysbiosis in COVID-19Busra Aktas, Belma AslimTurkish Journal of Biology = Turk Biyoloji Dergisi|November 13, 2025
Differential modulation of cisplatin efficacy by montelukast sodium and desloratadine in lung cancerSeha Akduman, Büşra Yüksel, Didem Tecimel, et al.Turkish Journal of Biology = Turk Biyoloji Dergisi|July 18, 2025
FDA-approved drugs as potential covalent inhibitors of key SARS-CoV-2 proteins: an in silico approachMurat Serilmez, Anwar Abuelrub, Ismail Erol, et al.Pageof 42